1. Search Result
Search Result
Isoforms Recommended: CCR9
Results for "

CCR9

" in MedChemExpress (MCE) Product Catalog:

17

Inhibitors & Agonists

1

Inhibitory Antibodies

3

Recombinant Proteins

1

Antibodies

6

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-15724
    Vercirnon
    3 Publications Verification

    GSK-1605786; CCX282-B; Traficet-EN

    CCR Ligands for Target Protein for PROTAC Inflammation/Immunology Endocrinology
    Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
    Vercirnon
  • HY-123763

    CCR Inflammation/Immunology
    MLN3126 is an orally active and potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis of mouse primary thymocytes, wiht an IC50 value of 6.3 nM for calcium influx .
    MLN3126
  • HY-15724A
    Vercirnon sodium
    3 Publications Verification

    GSK-1605786 sodium; CCX282-B sodium; Traficet-EN sodium

    CCR Inflammation/Immunology Endocrinology
    Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
    Vercirnon sodium
  • HY-117545

    RAR/RXR Cancer
    LE-540 is a selective retinoic acid receptor antagonist for RARβ (Ki=0.22 μM). LE-540 shows potential for use in cancer research, particularly for breast cancer and lung cancer .
    LE-540
  • HY-RS02174

    Small Interfering RNA (siRNA) Others

    Ccr9 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr9 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ccr9 Rat Pre-designed siRNA Set A
    Ccr9 Rat Pre-designed siRNA Set A
  • HY-RS02173

    Small Interfering RNA (siRNA) CCR Others

    Ccr9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccr9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ccr9 Mouse Pre-designed siRNA Set A
    Ccr9 Mouse Pre-designed siRNA Set A
  • HY-RS02172

    Small Interfering RNA (siRNA) CCR Others

    CCR9 Human Pre-designed siRNA Set A contains three designed siRNAs for CCR9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CCR9 Human Pre-designed siRNA Set A
    CCR9 Human Pre-designed siRNA Set A
  • HY-181287

    PROTACs CCR E1/E2/E3 Enzyme Inflammation/Immunology
    PROTAC CCR9 Degrader 1 is a PROTAC-based degrader targeting CCR9. PROTAC CCR9 Degrader 1 induces ubiquitination, proteasomal degradation of CCR9 and reduces intracellular CCR9 levels by recruiting the VHL E3 ligase. PROTAC CCR9 Degrader 1 has a Ki value of 78.0 nM against human CCR9. PROTAC CCR9 Degrader 1 modulates GPCR activity by binding to the intracellular allosteric binding site of CCR9. PROTAC CCR9 Degrader 1 can be used in research related to Crohn's disease .
    PROTAC CCR9 Degrader 1
  • HY-186003

    CCR Inflammation/Immunology
    CCR9 modulator-1 (example 16) is a CCR9 modulator.
    CCR9 modulator-1
  • HY-174740

    mRNA Inflammation/Immunology
    Human CCR9 mRNA encodes the human C-C motif chemokine receptor 9 (CCR9) protein, a member of the beta chemokine receptor family. CCR9 plays a role in directing immune responses to different segments of the gastrointestinal tract.
    Human CCR9 mRNA
  • HY-181288

    Target Protein Ligand-Linker Conjugates CCR Inflammation/Immunology
    CCR9 ligand-Linker Conjugate 1 is a target protein ligand-linker conjugate containing a CCR9 ligand and a PROTAC linker, which recruits E3 ligases. USP7 Ligand-Linker Conjugates 1 can be used to synthesize PROTAC CCR9 Degrader 1 (HY-181287) .
    CCR9 ligand-Linker Conjugate 1
  • HY-15724R

    GSK-1605786 (Standard); CCX282-B (Standard); Traficet-EN (Standard)

    CCR Reference Standards Inflammation/Immunology Endocrinology
    Vercirnon (Standard) is the analytical standard of Vercirnon. This product is intended for research and analytical applications. Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
    Vercirnon (Standard)
  • HY-15724AR

    GSK-1605786 sodium (Standard); CCX282-B sodium (Standard); Traficet-EN sodium (Standard)

    CCR Reference Standards Inflammation/Immunology Endocrinology
    Vercirnon (sodium) (Standard) is the analytical standard of Vercirnon (sodium). This product is intended for research and analytical applications. Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
    Vercirnon sodium (Standard)
  • HY-P992199

    CCR Inflammation/Immunology
    Anti-CCR9 Antibody is a monoclonal antibody targeting CCR9. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-CCR9 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-CCR9 Antibody
  • HY-113545

    9(R)-Hydroxyoctadecadienoic acid

    Endogenous Metabolite Metabolic Disease
    9(R)-HODE is a monohydroxy fatty acid and metabolite of linoleic acid. It is formed from linoleic acid by COX and lipoxygenase (LO).9(R)-HODE induces chemotaxis, increases the levels of chemokine (C-C motif) receptor 9 (CCR9) and chemokine (C-X-C motif) receptor 4 (CXCR4), and inhibits IL-6 release in primary human monocytes. It inhibits CD3α- and CD28-induced proliferation of isolated human peripheral blood lymphocytes when used at a concentration of 25 μg/mL.
    9(R)-HODE
  • HY-RS00161

    Small Interfering RNA (siRNA) Others

    ACKR2 Human Pre-designed siRNA Set A contains three designed siRNAs for ACKR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    ACKR2 Human Pre-designed siRNA Set A
    ACKR2 Human Pre-designed siRNA Set A
  • HY-RS20849

    Small Interfering RNA (siRNA) Others

    Ackr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ackr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ackr2 Mouse Pre-designed siRNA Set A
    Ackr2 Mouse Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: